EFFECTS OF M101-AN EXTRACELLULAR HEMOGLOBIN-APPLIED DURING CARDIOPULMONARY RESUSCITATION: AN EXPERIMENTAL RODENT STUDY.
Journal Information
Full Title: Shock
Abbreviation: Shock
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors report conflict of interests."
"This work was supported by a grant of the Zoll Foundation, Chelmsford, MA, USA, awarded to Dr. Michael Glas, and departmental funds of the Department of Intensive Care Medicine, University of Bern. The compound M101 was provided at no cost by Hemarina SA, 29600 Morlaix, France."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025